MétaCan
Menu
Back to cohort
Record W4413856487 · doi:10.1093/noajnl/vdaf166.004

6 ONC201 (DORDAVIPRONE) IN THE TREATMENT OF DIFFUSE MIDLINE GLIOMA OF THE PONS IN CHILDREN: CANCER CARE MANITOBA EXPERIENCE

2025· article· en· W4413856487 on OpenAlexaboutno aff
Meziane Brizini, Srikanth Kakumanu, Annie Drapeau, Colin Kazina, Patrick J. McDonald, Tina Drimes, Cathy Bourne, Jourdan Lubes, D Korones, Magimairajan Vanan

Bibliographic record

VenueNeuro-Oncology Advances · 2025
Typearticle
Languageen
FieldMedicine
TopicGlioma Diagnosis and Treatment
Canadian institutionsnot available
Fundersnot available
KeywordsPonsMedicineGliomaCancerInternal medicineCancer research

Abstract

fetched live from OpenAlex

Abstract Diffuse midline glioma of the pons (DMG-P) is a uniformly fatal brain tumor in children. Radiation therapy (RT) is the current standard of care with only transient benefits. Therapy at progression is very limited and offers marginal benefits. ONC201 (Dordaviprone), a brain penetrant dopamine receptor D2 antagonist has shown efficacy in recent clinical trials of DMG-P. Here we present our experience of DMG-P patients treated with ONC201. Methods: We analyzed clinical data of patients diagnosed with DMG-P from 2012-2024 and compared outcomes of patients treated with and without ONC201. Results: There were nineteen patients with DMG-P; Thirteen (N=13/19) patients were diagnosed based on clinical / MRI findings; six patients had biopsy confirmed DMG-P. All patients were treated with RT. Six (n=6/19, 31%) patients were treated with ONC201 at first recurrence post-RT through the expanded access program. Four of the six (N=4/6, 66%) patients also received repeat RT at first recurrence. ONC201 was tolerated well without any dose modifying toxicities. Median progression free survival (PFS) and median overall survival (OS) from initial diagnosis in the ONC201 vs. non-ONC201 patients was 9.05 months (4.5-30.1) compared to 4.6 months (1.9-10.7), and 19.2 months (11.3-33.1) compared to 8.2 months (1.9-19.7), respectively. Two patients are still alive (at 12 and 33 months) on therapy. Conclusion: Our data suggest that ONC201 in combination with repeat RT has clinical efficacy in the treatment of recurrent DMG-P tumors in children. Ongoing clinical trials of combination therapies of ONC201 in DMG-P both in upfront and recurrent settings will validate our findings.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame distilled prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

metaresearch head score (Codex)0.000
metaresearch head score (Gemma)0.000
Version: codex-gemma-dda1882f352aValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.083
Threshold uncertainty score0.571

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.0000.000
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0000.001
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0000.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.014
GPT teacher head0.328
Teacher spread0.314 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one teacher head, not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2025
Admission routes1
Has abstractyes

Explore more

Same venueNeuro-Oncology AdvancesSame topicGlioma Diagnosis and TreatmentFrench-language works237,207